Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
Ellen M. Apperloo(University Medical Center Groningen), Brendon L. Neuen(Royal North Shore Hospital), Robert A. Fletcher(UNSW Sydney), Niels Jongs(University Medical Center Groningen), Stefan D. Anker(German Centre for Cardiovascular Research), Deepak L. Bhatt(Mount Sinai Hospital), Javed Butler(University of Mississippi Medical Center), David Z.I. Cherney(University of Toronto), William G. Herrington(University of Oxford), Silvio E. Inzucchi(Yale University), Meg Jardine(The University of Sydney), Chih‐Chin Liu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kenneth W. Mahaffey(Stanford Medicine), Darren K. McGuire(Parkland Health & Hospital System), John J.V. McMurray(University of Glasgow), Bruce Neal(The George Institute for Global Health), Milton Packer(Baylor University Medical Center), Vlado Perkovic(UNSW Sydney), Marc S. Sabatine(Brigham and Women's Hospital), Scott D. Solomon(Brigham and Women's Hospital), Natalie Staplin(University of Oxford), Michael Szarek(University of Colorado Denver), Muthiah Vaduganathan(Brigham and Women's Hospital), Christoph Wanner(Universitätsklinikum Würzburg), David C. Wheeler(University College London), Stephen D. Wiviott(Brigham and Women's Hospital), Faïez Zannad(Inserm), Hiddo J.L. Heerspink(University Medical Center Groningen)
Cited by 126Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis